Masimo Corporation (NASDAQ:MASI) – Stock analysts at Wedbush upped their FY2017 earnings per share (EPS) estimates for Masimo Corporation in a research report issued on Wednesday. Wedbush analyst Levy. T now forecasts that the medical equipment provider will earn $2.96 per share for the year, up from their previous forecast of $2.80. Wedbush also issued estimates for Masimo Corporation’s FY2018 earnings at $2.75 EPS.

MASI has been the subject of a number of other reports. Stifel Nicolaus reaffirmed a “buy” rating and set a $108.00 price objective (up from $105.00) on shares of Masimo Corporation in a research note on Thursday, August 3rd. Zacks Investment Research cut Masimo Corporation from a “buy” rating to a “hold” rating in a research note on Tuesday, October 3rd. BidaskClub cut Masimo Corporation from a “buy” rating to a “hold” rating in a research note on Wednesday, July 5th. Roth Capital lifted their price objective on Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, July 19th. Finally, BTIG Research raised Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a research note on Monday, August 14th. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $97.00.

ILLEGAL ACTIVITY WARNING: This news story was reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/11/02/fy2017-eps-estimates-for-masimo-corporation-masi-raised-by-analyst.html.

Masimo Corporation (NASDAQ:MASI) last announced its earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.53 by $0.17. Masimo Corporation had a return on equity of 22.89% and a net margin of 45.83%. The business had revenue of $193.69 million during the quarter, compared to analysts’ expectations of $189.01 million. During the same quarter last year, the business posted $0.52 earnings per share. The company’s quarterly revenue was up 15.6% on a year-over-year basis.

In other Masimo Corporation news, Director Sanford Fitch sold 11,000 shares of the business’s stock in a transaction dated Thursday, August 17th. The stock was sold at an average price of $87.25, for a total value of $959,750.00. Following the completion of the transaction, the director now directly owns 72,249 shares of the company’s stock, valued at $6,303,725.25. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 16.60% of the stock is currently owned by insiders.

Large investors have recently bought and sold shares of the business. Prudential Financial Inc. grew its stake in Masimo Corporation by 14.4% in the second quarter. Prudential Financial Inc. now owns 553,215 shares of the medical equipment provider’s stock valued at $50,442,000 after acquiring an additional 69,810 shares during the period. American Century Companies Inc. grew its stake in Masimo Corporation by 98.0% in the second quarter. American Century Companies Inc. now owns 209,474 shares of the medical equipment provider’s stock valued at $19,100,000 after acquiring an additional 103,656 shares during the period. D L Carlson Investment Group Inc. grew its stake in Masimo Corporation by 32.4% in the second quarter. D L Carlson Investment Group Inc. now owns 46,240 shares of the medical equipment provider’s stock valued at $4,216,000 after acquiring an additional 11,315 shares during the period. State Street Corp grew its stake in Masimo Corporation by 10.4% in the second quarter. State Street Corp now owns 1,547,728 shares of the medical equipment provider’s stock valued at $141,121,000 after acquiring an additional 146,212 shares during the period. Finally, Robeco Institutional Asset Management B.V. grew its stake in Masimo Corporation by 27.1% in the second quarter. Robeco Institutional Asset Management B.V. now owns 1,095,353 shares of the medical equipment provider’s stock valued at $99,872,000 after acquiring an additional 233,412 shares during the period. 82.96% of the stock is owned by hedge funds and other institutional investors.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Earnings History and Estimates for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.